Showing results (31-40 of 222) with videos related to
Sort By:
Pageof 23
International Journal of Immunopharmacology|January 1, 1982
Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsyN E Gilhus, R Matre, J A AarliInternational Journal of Immunopharmacology|January 1, 1982
Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiencyN E Gilhus, R Matre, J A AarliActa Neurologica Scandinavica|November 1, 1983
Myasthenia gravis: the specificities of skeletal muscle and thymus antibodiesN E Gilhus, J A Aarli, R MatreActa Neurologica Scandinavica|July 1, 1987
CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?J A Aarli, N E Gilhus, H HofstadActa Neurologica Scandinavica|January 13, 2005
Myasthenia gravis: clinical, immunological, and therapeutic advancesF Romi, N E Gilhus, J A AarliTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 10, 1990
[Myasthenia gravis and thymoma]B Gundersen, N E Gilhus, J A AarliInternational Journal of Immunopharmacology|January 1, 1982
HLA antigens in epileptic patients with drug-induced immunodeficiencyN E Gilhus, J A Aarli, E ThorsbyActa Neurologica Scandinavica|October 1, 1990
Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravisC A Vedeler, N E Gilhus, R MatreNeurology|February 1, 1984
Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodiesN E Gilhus, J A Aarli, R MatreJournal of Neuroimmunology|December 1, 1983
Myasthenia gravis. Antibodies to skeletal muscle cell surface antigensN E Gilhus, J A Aarli, R MatrePageof 23